Binge Eating Disorder involves recurrent binge eating without compensatory behaviors, marked distress about eating, and frequent comorbidity with mood/anxiety disorders and obesity.
From your prerequisite study of eating disorders broadly, you know that eating disorders are defined by their behavioral patterns and the degree to which they distort normal feeding behavior. Binge Eating Disorder (BED) is the most common eating disorder and the one most frequently confused with simple overeating. The clinical distinction is crucial: BED involves discrete binge episodes characterized by eating a definitively large amount of food in a bounded time period (typically under two hours) combined with a subjective loss of control — not just feeling full, but feeling unable to stop eating even when wanting to.
What distinguishes BED from bulimia nervosa is the absence of compensatory behaviors. In bulimia, binge-purge cycles create a partial reset and are often driven by body image distortion. In BED, there is no purging, excessive exercise, or fasting to offset the binge. Individuals with BED frequently experience severe shame, disgust, and distress after episodes; paradoxically, the binge may temporarily relieve negative emotional states before triggering that secondary distress. This is the negative reinforcement cycle at the core of BED's maintenance: bingeing reduces immediate emotional discomfort, which increases the likelihood of future bingeing as an emotion regulation strategy, which then generates shame that itself becomes a trigger for further emotional dysregulation.
BED has high rates of comorbidity with mood disorders (particularly depression), anxiety disorders, and obesity, though BED is not defined by or reducible to obesity — many people with obesity do not have BED, and BED occurs across a range of body weights. The direction of causation between BED and depression is bidirectional: depression can drive emotional eating, and the consequences of BED (weight gain, social withdrawal, shame) deepen depression. Neurobiologically, BED shows dysregulation in reward and inhibitory control circuits similar to other behavioral addictions, particularly in dopaminergic pathways governing impulsive responding to food cues.
Treatment evidence centers on Cognitive Behavioral Therapy (CBT), which targets the thought patterns and behaviors maintaining the disorder — distorted cognitions about food, restriction-binge cycles, and emotional avoidance. Pharmacologically, lisdexamfetamine (an ADHD medication) has FDA approval specifically for moderate-to-severe BED, reducing binge frequency via dopaminergic and noradrenergic mechanisms that improve inhibitory control. This shared pharmacology with ADHD is not coincidental: impulsivity and difficulty inhibiting prepotent responses are central features of BED, and the overlap reinforces the view of BED as a disorder of reward circuitry rather than simply a problem of willpower or motivation.
No topics depend on this one yet.